Enanta Pharma (ENTA) Tops Q1 EPS by 39c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.42), $0.39 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Blue Star Gold closes final tranche of flow-through private placement